Guinea vs Guinea-Bissau: Treatment coverage for lymphatic filariasis
Guinea
67.5%
in 2024
Guinea-Bissau
66.9%
in 2024
Guinea rank
32nd
Guinea-Bissau rank
34th
Treatment coverage for lymphatic filariasis over time
- Guinea
- Guinea-Bissau
How they compare
Guinea currently reports 67.5% against 66.9% in Guinea-Bissau, a difference of 0.6%.
The two have swapped places 3 times across 11 shared years of data; in 2014 it was Guinea-Bissau ahead.
Guinea ranks 32nd and Guinea-Bissau ranks 34th of 66 countries.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.1% | 38.5% | 6.6% | Guinea |
| 2020s | 60.0% | 34.4% | 25.6% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Guinea or Guinea-Bissau?
- Guinea, at 67.5% against 66.9% in Guinea-Bissau as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Guinea and Guinea-Bissau?
- 0.6%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Guinea-Bissau?
- 11 years are reported by both, from 2014 to 2024.
- How do Guinea and Guinea-Bissau rank globally for treatment coverage for lymphatic filariasis?
- Guinea ranks 32nd and Guinea-Bissau ranks 34th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.